Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review – 2021
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The pharmaceutical and healthcare sector mergers, acquisitions, and investment trend report is an essential source of data and trend analysis on partnerships, licensing mergers, and acquisitions (M&As), and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceutical industry in the year 2021. It also portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceutical industry.
What is the regional level outlook of the global pharmaceutical and healthcare market?
The key regions in the global pharmaceutical and healthcare market are North America, Europe, Asia-Pacific, and the Rest of the World (ROW).
Global Pharmaceutical and Healthcare Market Analysis by Regions
For more regional insights, download a free report sample
What are the key deal types in the global pharmaceutical and healthcare market?
The key deal types in the global pharmaceutical and healthcare market are global M&A deals, equity offering deals, debt offering deals, partnership deals, licensing agreements, private equity deals, and venture capital deals.
Global Pharmaceutical and Healthcare Market Analysis by Deal Types
For more deal type insights, download a free report sample
Which are the key market deals in the global pharmaceutical and healthcare market?
The key market deals in the global pharmaceutical and healthcare market are oncology deals, central nervous system deals, infectious disease deals, immunology deals, cardiovascular deals, metabolic disorders deals, and gastrointestinal deals.
Global Pharmaceutical and Healthcare Market Analysis by Market Deals
For more market deals insights, download a free report sample
Who are the leading financial advisors in the global pharmaceutical and healthcare market?
Some of the leading financial advisors in the global pharmaceutical and healthcare market are The Goldman Sachs Group Inc, Centerview Partners LLC, J.P. Morgan Securities LLC, Morgan Stanley, Rothschild & Co SCA, Jefferies LLC, SVB Financial Group, Cowen Inc, Bank of America Corp, and Barclays Plc.
The Goldman Sachs Group Inc participated in the major number of M&A deals while Jefferies LLC participated in the major number of the equity offering deals in the pharmaceutical and healthcare industry in 2021.
Leading M&A financial advisors in the global pharmaceutical and healthcare market
To know more about leading financial advisors, download a free report sample
Market Report Scope
Key regions | North America, Europe, Asia-Pacific, and Rest of the World (ROW) |
Key deal types | Global M&A Deals, Equity Offering Deals, Debt Offering Deals, Partnership Deals, Licensing Agreements, Private Equity Deals, and Venture Capital Deals |
Key market deals | Oncology Deals, Central Nervous System Deals, Infectious Disease Deals, Immunology Deals, Cardiovascular Deals, Metabolic Disorders Deals, and Gastrointestinal Deals |
Leading financial advisors | The Goldman Sachs Group Inc, Centerview Partners LLC, J.P. Morgan Securities LLC, Morgan Stanley, Rothschild & Co SCA, Jefferies LLC, SVB Financial Group, Cowen Inc, Bank of America Corp, and Barclays Plc |
Scope
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genitourinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas that are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals that happened in the pharmaceutical industry.
- Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to Buy
- Enhance your decision-making capability in a more rapid and time-sensitive manner.
- Find out the major deal-performing segments for investments in your industry.
- Evaluate the types of companies that are entering into partnership or licensing agreements, divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving most of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where most of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
Table of Contents
Frequently asked questions
-
Which are the key regions in the global pharmaceutical and healthcare market?
The key regions in the global pharmaceutical and healthcare market are North America, Europe, Asia-Pacific, and the Rest of the World (ROW).
-
What are the key deal types in the global pharmaceutical and healthcare market?
The key deal types in the global pharmaceutical and healthcare market are global M&A deals, equity offering deals, debt offering deals, partnership deals, licensing agreements, private equity deals, and venture capital deals.
-
Which are the key market deals in the global pharmaceutical and healthcare market?
The key market deals in the global pharmaceutical and healthcare market are oncology deals, central nervous system deals, infectious disease deals, immunology deals, cardiovascular deals, metabolic disorders deals, and gastrointestinal deals.
-
Who are the leading financial advisors in the global pharmaceutical and healthcare market?
Some of the leading financial advisors in the global pharmaceutical and healthcare market are The Goldman Sachs Group Inc, Centerview Partners LLC, J.P. Morgan Securities LLC, Morgan Stanley, Rothschild & Co SCA, Jefferies LLC, SVB Financial Group, Cowen Inc, Bank of America Corp, and Barclays Plc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Pharmaceuticals reports

